CSDX CS Diagnostics Corp.
Fundamentals / CIK 0001106861 / USDCS Diagnostics Corp. reported $499.4M in total assets through September 30, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CSDX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Sep 30, 2025
-
Operating Income FY 2025-- Operating profit
-
Net Income FY 2025-- GAAP bottom line
-
Diluted EPS FY 2025-- Split-adjusted
-
Free Cash Flow FY 2025-- Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2025$13 Total debt: --
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2025-09-30 | 2024-09-30 |
|---|---|---|
| Revenue | $23K | $8.0K |
| Research & Development | $0 | -- |
| Total Operating Expenses | $23K | $7.4K |
| Operating Income | -$182 | $536 |
| Net Income | -$182 | $536 |
| Basic EPS | $0.00 | $0.00 |
| Diluted EPS | $0.00 | $0.00 |
| Basic Shares Outstanding | 137.4M | 129.8M |
| Diluted Shares Outstanding | 137.4M | 129.8M |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2025-09-30 | 2024-12-31 |
|---|---|---|
| Cash & Cash Equivalents | $13 | $501 |
| Cash & Short-Term Investments | $13 | $501 |
| Total Current Assets | $31K | $501 |
| Total Non-Current Assets | $499.4M | $499.4M |
| Total Assets | $499.4M | $499.4M |
| Accounts Payable | $1.6K | $1.4K |
| Total Liabilities | $1.6K | $1.4K |
| Common Stock | $1.4K | $1.4K |
| Retained Earnings | -$4.74M | -$4.77M |
| Total Stockholders' Equity | $499.4M | $499.4M |
| Total Equity | $499.4M | $499.4M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2025-09-30 |
|---|---|
| Net Income | -$182 |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2025-09-30 | 2024-09-30 |
|---|---|---|
| Revenue Growth (YoY) | +189.4% | -- |
| Operating Income Growth (YoY) | -134.0% | -- |
| Net Income Growth (YoY) | -134.0% | -- |